[go: up one dir, main page]

ES2102322A1 - Procedimiento de preparacion de didemnina a. - Google Patents

Procedimiento de preparacion de didemnina a.

Info

Publication number
ES2102322A1
ES2102322A1 ES09501411A ES9501411A ES2102322A1 ES 2102322 A1 ES2102322 A1 ES 2102322A1 ES 09501411 A ES09501411 A ES 09501411A ES 9501411 A ES9501411 A ES 9501411A ES 2102322 A1 ES2102322 A1 ES 2102322A1
Authority
ES
Spain
Prior art keywords
didemnine
boc
coupling
preparation
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09501411A
Other languages
English (en)
Other versions
ES2102322B1 (es
Inventor
Lledo Ernest Giralt
Palomera Fernando Albericio
Paul Lloyud-Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Priority to ES09501411A priority Critical patent/ES2102322B1/es
Publication of ES2102322A1 publication Critical patent/ES2102322A1/es
Application granted granted Critical
Publication of ES2102322B1 publication Critical patent/ES2102322B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE DIDEMNINA A. COMPRENDE: (A) ACOPLAR LAS UNIDADES Z-N(ME)-O(ME)-TYR-O[BOC-THR]-OH Y H-IST-HIP-LEU-PRO-OBZL.HCL EN PRESENCIA DE HBTU Y DIEA; (B) DESPROTEGER SIMULTANEAMENTE LOS EXTREMOS N- Y C-TERMINAL DEL PRODUCTO OBTENIDO; (C) CICLAR EL PRODUCTO DE LA ETAPA (B) EMPLEANDO EL ACOPLANTE HBTU Y EN PRESENCIA DE HOBT Y DIEA, PARA PRODUCIR UN MACROCICLO CON EL N-TERMINAL DE LA THR PROTEGIDO; (D) DESPROTEGER DICHO GRUPO Y ACOPLAR EL MACROCICLO CON BOC-(R)-NMELEU-OH PARA PRODUCIR LA BOC-DIDEMNINA A; (E) HACER REACCIONAR ESTE ULTIMO PRODUCTO CON ACIDO TRIFLUORACETICO PARA OBTENER LA DIDEMNINA A. LA DIDEMNINA A TIENE APLICACION COMO AGENTE ANTITUMORAL, ANTIVIRAL E INMUNOSUPRESOR.
ES09501411A 1995-07-13 1995-07-13 Procedimiento de preparacion de didemnina a. Expired - Fee Related ES2102322B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES09501411A ES2102322B1 (es) 1995-07-13 1995-07-13 Procedimiento de preparacion de didemnina a.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09501411A ES2102322B1 (es) 1995-07-13 1995-07-13 Procedimiento de preparacion de didemnina a.

Publications (2)

Publication Number Publication Date
ES2102322A1 true ES2102322A1 (es) 1997-07-16
ES2102322B1 ES2102322B1 (es) 1998-03-01

Family

ID=8291039

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09501411A Expired - Fee Related ES2102322B1 (es) 1995-07-13 1995-07-13 Procedimiento de preparacion de didemnina a.

Country Status (1)

Country Link
ES (1) ES2102322B1 (es)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002596A3 (en) * 2000-06-30 2002-05-23 Pharma Mar Sa Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
US7348311B2 (en) 1989-09-29 2008-03-25 Pharma Mar, S.A. Derivatives of dehydrodidemnin B
US7381703B2 (en) 2003-03-12 2008-06-03 Dana-Faber Cancer Institute, Inc. Aplidine for multiple myeloma treatment
US7507766B2 (en) 2000-10-12 2009-03-24 Pharma Mar, S.A. Treatment of cancers
US7576188B2 (en) 2003-03-12 2009-08-18 Pharma Mar, S.A.U. Antitumoral treatments
US7651997B2 (en) 2000-04-07 2010-01-26 The Trustees Of The University Of Pennsylvania Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them
US7737114B2 (en) 2000-04-07 2010-06-15 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
US8030279B2 (en) 2003-03-21 2011-10-04 The Trustees Of The University Of Pennsylvania Tamandarin analogs and fragments thereof and methods of making and using
US8420130B1 (en) 1998-02-18 2013-04-16 Pharma Mar S.A. Pharmaceutical formulation of a didemnin compound
US10538535B2 (en) 2017-04-27 2020-01-21 Pharma Mar, S.A. Antitumoral compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004985A1 (en) * 1989-09-29 1991-04-18 Pharma Mar S.A. Dehydrodidemnin b
WO1993000362A1 (de) * 1991-06-20 1993-01-07 Basf Aktiengesellschaft Neue peptide (didemnine), ihre herstellung und verwendung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004985A1 (en) * 1989-09-29 1991-04-18 Pharma Mar S.A. Dehydrodidemnin b
WO1993000362A1 (de) * 1991-06-20 1993-01-07 Basf Aktiengesellschaft Neue peptide (didemnine), ihre herstellung und verwendung

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7348311B2 (en) 1989-09-29 2008-03-25 Pharma Mar, S.A. Derivatives of dehydrodidemnin B
US8420130B1 (en) 1998-02-18 2013-04-16 Pharma Mar S.A. Pharmaceutical formulation of a didemnin compound
US7737114B2 (en) 2000-04-07 2010-06-15 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
US7651997B2 (en) 2000-04-07 2010-01-26 The Trustees Of The University Of Pennsylvania Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them
US7348310B2 (en) 2000-06-30 2008-03-25 Pharma Mar, S.A. Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
CZ304204B6 (cs) * 2000-06-30 2014-01-02 Pharma Mar, S. A. Deriváty aplidinu
WO2002002596A3 (en) * 2000-06-30 2002-05-23 Pharma Mar Sa Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
US7678765B2 (en) 2000-06-30 2010-03-16 Pharma Mar, S.A. Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
US7507766B2 (en) 2000-10-12 2009-03-24 Pharma Mar, S.A. Treatment of cancers
US7576188B2 (en) 2003-03-12 2009-08-18 Pharma Mar, S.A.U. Antitumoral treatments
US7381703B2 (en) 2003-03-12 2008-06-03 Dana-Faber Cancer Institute, Inc. Aplidine for multiple myeloma treatment
US8030279B2 (en) 2003-03-21 2011-10-04 The Trustees Of The University Of Pennsylvania Tamandarin analogs and fragments thereof and methods of making and using
US10538535B2 (en) 2017-04-27 2020-01-21 Pharma Mar, S.A. Antitumoral compounds
US11332480B2 (en) 2017-04-27 2022-05-17 Pharma Mar, S.A. Antitumoral compounds
US11339180B2 (en) 2017-04-27 2022-05-24 Pharma Mar, S.A. Antitumoral compounds
US11713325B2 (en) 2017-04-27 2023-08-01 Pharma Mar, S.A. Antitumoral compounds
US12384800B2 (en) 2017-04-27 2025-08-12 Pharma Mar, S.A. Antitumoral compounds

Also Published As

Publication number Publication date
ES2102322B1 (es) 1998-03-01

Similar Documents

Publication Publication Date Title
CA2265900A1 (en) Improved solid-phase peptide synthesis and agent for use in such synthesis
AU592309B2 (en) Potent thymopentin analogs
ES2102322A1 (es) Procedimiento de preparacion de didemnina a.
GB9720054D0 (en) Biological products
AU633913B2 (en) Novel tnf-inhibit proteins and their preparation
WO1994001451A3 (en) Method for modification of recombinant polypeptides
KR100237126B1 (ko) 펩티드 유사체의 신속한 합성 및 검색방법
IE800514L (en) Tripeptides
SHIMOHIGASHI et al. Synthesis and biological activity of ΔPhe4‐enkephalins
WO1993019178A3 (en) Peptides useful for inducing tolerance
López-Macià et al. Kahalalide B. Synthesis of a natural cyclodepsipeptide
Sugg et al. Cyclic lactam analogs of Ac-[Nle4]. alpha.-MSH4-11-NH2
Shenbagamurthi et al. Biological activity and conformational isomerism in position 9 analogs of the des-1-tryptophan, 3. beta.-cyclohexylalanine-. alpha.-factor from Saccharomyces cerevisiae
ES8507474A1 (es) Procedimiento para preparar ciclopeptidos
US9850274B2 (en) Peptide combination
Moroder et al. Studies on cytochrome c. Part I. Synthesis of the protected hexadecapeptide (sequence 1–16) of Baker's Yeast iso‐1‐cytochrome c
AU2002222439B2 (en) Process for the synthesis of a peptide having a tryptophan residue
CA2223911A1 (en) The preparation of active peptides
ATE30919T1 (de) Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
YANAIHARA et al. Studies on the synthesis of proinsulin. I. Synthesis of partially protected tritriacontapeptide related to the connecting peptide fragment of porcine proinsulin
Fahrenholz et al. Synthesis and biological activities of arginine-vasopressin analogues with reactive groups
EP0438600A4 (en) Enzymes which participate in c-terminal amidation, and production and use thereof
CA2047119A1 (en) Vitro processing of fusion proteins
Visser et al. Studies on polypeptides. Part IX: Combination of solid‐phase and classical methods of peptide synthesis in the preparation of 1‐13 [13‐Leucine] bovine pancreatic ribonuclease
Mann et al. A synthetic analogue of the carboxylate-binding pocket of vancomycin

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970716

Kind code of ref document: A1

Effective date: 19970716

FD2A Announcement of lapse in spain

Effective date: 20151026